Theriva biologics to host conference call and webcast to discuss fourth quarter and full-year 2022 operational highlights and financial results

Rockville, md., march 20, 2023 (globe newswire) -- theriva biologics (nyse american: tovx), a diversified clinical-stage company developing therapeutics designed to treat cancer and related diseases in areas of high unmet need, today announced that it plans to host a conference call on monday, march 27, 2023, at 8:30 a.m. et to discuss its financial results for the fourth quarter and full-year ended december 31, 2022 and provide a corporate update.
TOVX Ratings Summary
TOVX Quant Ranking